Edesa Biotech Inc (EDSA)
4.420
-0.05
(-1.09%)
USD |
NASDAQ |
Apr 26, 16:00
Edesa Biotech Price to Book Value: 2.398 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 2.398 |
| April 25, 2024 | 2.425 |
| April 24, 2024 | 2.339 |
| April 23, 2024 | 2.423 |
| April 22, 2024 | 2.377 |
| April 19, 2024 | 2.415 |
| April 18, 2024 | 2.366 |
| April 17, 2024 | 2.388 |
| April 16, 2024 | 2.358 |
| April 15, 2024 | 2.258 |
| April 12, 2024 | 2.431 |
| April 11, 2024 | 2.431 |
| April 10, 2024 | 2.542 |
| April 09, 2024 | 2.464 |
| April 08, 2024 | 2.523 |
| April 05, 2024 | 2.537 |
| April 04, 2024 | 2.604 |
| April 03, 2024 | 2.366 |
| April 02, 2024 | 2.388 |
| April 01, 2024 | 2.301 |
| March 28, 2024 | 2.275 |
| March 27, 2024 | 2.415 |
| March 26, 2024 | 2.236 |
| March 25, 2024 | 2.267 |
| March 22, 2024 | 2.323 |
| Date | Value |
|---|---|
| March 21, 2024 | 2.220 |
| March 20, 2024 | 2.344 |
| March 19, 2024 | 2.230 |
| March 18, 2024 | 2.334 |
| March 15, 2024 | 2.382 |
| March 14, 2024 | 2.366 |
| March 13, 2024 | 2.350 |
| March 12, 2024 | 2.469 |
| March 11, 2024 | 2.474 |
| March 08, 2024 | 2.457 |
| March 07, 2024 | 2.361 |
| March 06, 2024 | 2.342 |
| March 05, 2024 | 2.393 |
| March 04, 2024 | 2.469 |
| March 01, 2024 | 2.610 |
| February 29, 2024 | 2.506 |
| February 28, 2024 | 2.692 |
| February 27, 2024 | 2.713 |
| February 26, 2024 | 2.720 |
| February 23, 2024 | 2.708 |
| February 22, 2024 | 2.550 |
| February 21, 2024 | 2.800 |
| February 20, 2024 | 2.952 |
| February 16, 2024 | 2.914 |
| February 15, 2024 | 3.066 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.651
Minimum
May 06 2019
16.44
Maximum
Aug 31 2020
4.616
Average
3.863
Median
Apr 05 2021
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4214 |
| Aurinia Pharmaceuticals Inc | 1.879 |
| Lexaria Bioscience Corp | 4.644 |
| Xenon Pharmaceuticals Inc | 3.292 |
| ESSA Pharma Inc | 1.912 |
Price to Book Value Related Metrics
| PS Ratio | 40.29 |
| Price | 4.420 |
| Earnings Yield | -59.72% |
| Market Cap | 14.02M |